Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Nel ASA Secures EU Backing for Next-Generation Hydrogen Technology

Dieter Jaworski by Dieter Jaworski
December 13, 2025
in Analysis, European Markets, Hydrogen, Renewable Energy, Turnaround
0
Nel ASA Stock
0
SHARES
31
VIEWS
Share on FacebookShare on Twitter

Norwegian hydrogen specialist Nel ASA has reached a pivotal strategic milestone. After seven years in development, the company’s board has given the final investment decision to construct up to one gigawatt of production capacity for its new electrolyzer platform. The move, announced Friday and supported by substantial European Union funding, aims to drastically improve the efficiency and economics of hydrogen production. The critical question for investors is whether this technological leap can provide a lasting foundation for the company’s recently volatile share price.

Financial Momentum and Market Reaction

The market’s initial response to the news was positive, with Nel’s shares advancing over 4% to 2.38 NOK. Central to the announcement is the commercialization of the firm’s “Next Generation Pressurized Alkaline” (NGP) systems. A key enabler for the project is financial support from the European Union’s Innovation Fund, which has committed grants covering up to 60% of relevant capital and operational expenditures, amounting to as much as 135 million euros. This commitment has triggered an immediate first disbursement of over 10 million euros.

CEO Håkon Volldal emphasized that the NGP technology is designed to reduce hydrogen costs to a level where business models can achieve profitability without relying heavily on subsidies.

Operational Challenges Amid Strategic Progress

This strategic shift comes against a backdrop of mixed operational results. Nel’s third-quarter report showed a 17% year-over-year revenue decline to 303 million Norwegian kroner. However, the company managed to significantly narrow its EBITDA loss, which improved from 90 million NOK to 37 million NOK.

Despite the recent quarterly revenue weakness, new business activity has been robust. In November alone, Nel secured an order worth more than $50 million for two 20-megawatt electrolyzer plants in Norway, marking the second-largest firm order in its history. The company’s order backlog remained solid at 984 million NOK as of the end of September.

Should investors sell immediately? Or is it worth buying Nel ASA?

Technological Advancements and Potential Write-Downs

The new technology represents a radical simplification in system design. It utilizes a modular, skid-based approach where fully assembled and pre-tested containerized units are delivered, eliminating complex on-site construction for customers and allowing for outdoor installation.

This progress, however, carries a potential financial implication for the balance sheet. Because the new pressurized technology is expected to be significantly more cost-effective, management is reviewing the book value of its existing, currently idled production lines for atmospheric alkaline electrolyzers. Investors may need to prepare for potential asset impairments as these older lines risk becoming obsolete.

Analyst Caution and the Road Ahead

The commercial launch for the new technology platform is scheduled for the first half of 2026, with scaling operations expected to follow in 2027. While the recent developments are positive, analyst sentiment remains cautious. The prevailing market consensus recommendation continues to be predominantly “Underweight,” although some institutions, including Citi, have modestly raised their price targets—Citi’s now stands at 2.70 NOK.

Further clarity on the financial trajectory will likely come with Nel’s fourth-quarter results, scheduled for release in late February 2026. Until then, the investment thesis for the stock hinges largely on the new platform’s ability to deliver its promised substantial reductions in the cost of hydrogen.

Ad

Nel ASA Stock: Buy or Sell?! New Nel ASA Analysis from February 7 delivers the answer:

The latest Nel ASA figures speak for themselves: Urgent action needed for Nel ASA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Nel ASA: Buy or sell? Read more here...

Tags: Nel ASA
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Camping World Stock
Consumer & Luxury

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock
Analysis

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Next Post
XRP Stock

XRP's Pivotal Battle at the $2 Threshold

Boeing Stock

Boeing's Order Surge Faces Regulatory Hurdles

Adobe Stock

Adobe's AI Ambitions Come at a Cost to Profitability

Recommended

Dare Bioscience Stock

Dare Bioscience Stock: Analysts Project Triple-Digit Upside Potential

4 months ago
Bloom Energy Stock

Fuel Cell Leader Bloom Energy Capitalizes on AI Infrastructure Demand

3 months ago
AI travel

NextTrip Inc Announces Official Transition and Ticker Symbol Change

2 years ago
Genprex Stock

Genprex Shares Plunge Amid Heavy Selling Pressure

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

Trending

Camping World Stock
Consumer & Luxury

Camping World’s New Leadership Faces First Major Test

by Jackson Burston
February 7, 2026
0

All eyes are on Camping World Holdings as it approaches a pivotal quarterly report. This will be...

Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Camping World’s New Leadership Faces First Major Test
  • Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment
  • Diginex Enters Critical Implementation Phase Following Strategic Moves

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com